Press Releases from DelveInsight Business Research LLP (4878 total)
Cystinosis FDA Approvals, Clinical Trials and Pipeline Insights 2024 | AVROBIO, …
DelveInsight's 'Cystinosis Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Cystinosis therapies in various stages of clinical development, major pharmaceutical…
Cytokine Release Syndrome FDA Approvals, Clinical Trials and Pipeline Insights 2 …
DelveInsight's 'Cytokine Release Syndrome Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Cytokine Release Syndrome therapies in various stages of…
Cytomegalovirus FDA Approvals, Clinical Trials and Pipeline Insights 2024 | Mode …
DelveInsight's 'Cytomegalovirus Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Cytomegalovirus therapies in various stages of clinical development, major pharmaceutical…
Cutaneous Lupus Erythematosus FDA Approvals, Clinical Trials and Pipeline Insigh …
United States, Nevada, Las Vegas, DelveInsight's 'Cutaneous Lupus Erythematosus Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Cutaneous Lupus Erythematosus…
Deep Vein Thrombosis FDA Approvals, Clinical Trials and Pipeline Insights 2024 | …
United States, Nevada, Las Vegas, DelveInsight's 'Deep Vein Thrombosis Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Deep Vein Thrombosis…
Sepsis Drugs Market Size 2034 | La Jolla Pharmaceuticals, Par Pharmaceutical, On …
Sepsis Market Insights, Epidemiology, and Market Forecast-2034" offers a comprehensive understanding of Sepsis, including historical and projected epidemiology. Additionally, the report examines market trends for…
Aplastic Anemia Drugs Market Size 2034 | Pfizer, BioLineRx, Ltd., Regeneron Phar …
DelveInsight's "Aplastic Anemia Market Insights, Epidemiology and Market Forecast - 2034" report delivers an in-depth understanding of the aplastic anemia, historical and forecasted epidemiology as…
Nephrotic Syndrome Drugs Market Size 2034 | GlaxoSmithKline, Goldfinch Bio, Inc. …
DelveInsight's "Nephrotic Syndrome Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of the Nephrotic Syndrome, historical and forecasted epidemiology, and…
Complement 3 Glomerulopathy Drugs Market Size 2034 | ChemoCentryx, Novartis Phar …
DelveInsight's "Complement 3 Glomerulopathy Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of Complement 3 Glomerulopathy, historical and forecasted epidemiology…
Geographic Atrophy Drugs Market Size 2032 | Apellis Pharmaceuticals, Iveric Bio …
DelveInsight's "Geographic Atrophy Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Geographic Atrophy, historical and forecasted epidemiology as well as…
Hidradenitis Suppurativa Drugs Market Size 2034 | Inflarx, Novartis Pharmaceutic …
DelveInsight's "Hidradenitis Suppurativa Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of Hidradenitis Suppurativa, historical and forecasted epidemiology as well…
Glaucoma Drugs Market Size 2032 | Allergan, Sun Pharma Advanced Research Company …
DelveInsight's "Glaucoma Market Insights, Epidemiology and Market Forecast - 2034" report delivers an in-depth understanding of the Glaucoma, historical and forecasted epidemiology and the Glaucoma…
Retinitis Pigmentosa Drugs Market Size 2032 | Johnson & Johnson Innovative Medic …
DelveInsight's "Retinitis Pigmentosa Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of historical and forecasted epidemiology as well as the…
Peanut Allergy Drugs Market Size 2032 | Parexel, Regeneron Pharmaceuticals, Sano …
DelveInsight's "Peanut Allergy Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Peanut Allergy, historical and forecasted epidemiology as well as…
Glioblastoma Multiforme Drugs Market Size 2032 | Genentech, Merck, Daiichi Sanky …
DelveInsight's 'Glioblastoma Multiforme Market Insights, Epidemiology and Market Forecast- 2032' report delivers an in-depth understanding of the Glioblastoma Multiforme, historical and forecasted epidemiology as well…
Cutaneous Lupus Erythematosus Clinical Trials, Emerging Therapies, Key Companies …
DelveInsight's 'Cutaneous Lupus Erythematosus Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Cutaneous Lupus Erythematosus therapies in various stages of…
Dravet Syndrome Clinical Trials | A Drug Pipeline Analysis Report 2024 | Compani …
DelveInsight's 'Dravet Syndrome Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Dravet Syndrome therapies in various stages of clinical development;…
Diabetic Retinopathy Clinical Trials | A Drug Pipeline Analysis Report 2024 | Co …
DelveInsight's 'Diabetic Retinopathy Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Diabetic Retinopathy therapies in various stages of clinical development,…
Cutaneous T-Cell Lymphoma Clinical Trials | A Drug Pipeline Analysis Report 2024 …
DelveInsight's 'Cutaneous T-Cell Lymphoma Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Cutaneous T-Cell Lymphoma therapies in various stages of…
Cystic Fibrosis Clinical Trials | A Drug Pipeline Analysis Report 2024 | Compani …
DelveInsight's 'Cystic Fibrosis Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Cystic Fibrosis therapies in various stages of clinical development,…
Heart Failure Drugs Market Size 2032 | Roche, Pfizer, Novo Nordisk, Merck & Co, …
DelveInsight's "Heart Failure Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Heart Failure, historical and forecasted epidemiology as well as…
Synovial Sarcoma Drugs Market Size 2032 | Takara Bio Inc., Foghorn Therapeutics …
DelveInsight's "Synovial Sarcoma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Synovial Sarcoma, historical and forecasted epidemiology as well as…
Cutaneous T-Cell Lymphoma Drugs Market Size 2034 | BeiGene, Galderma R&D, Angimm …
DelveInsight's report titled "Cutaneous T-Cell Lymphoma Therapeutics Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of burns, historical and forecasted…
Parainfluenza Virus Infection Drugs Market Size 2032 | ModernaTX Inc., MedImmune …
DelveInsight's "Parainfluenza Virus Infection Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Parainfluenza Virus Infection, historical and forecasted epidemiology as…
Chronic Kidney Disease FDA Approvals, Emerging Drugs, and Pipeline 2024 | Boehri …
DelveInsight's, "Chronic Kidney Disease Pipeline Insight 2024" report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in the Chronic Kidney Disease pipeline landscape.…
Cirrhosis FDA Approvals, Clinical Trials and Pipeline Insights 2024 | GWOXI Stem …
DelveInsight's, "Cirrhosis Pipeline Insight 2024" report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in the Cirrhosis pipeline landscape. It covers the Cirrhosis…
Alpha-1 Antitrypsin Deficiency FDA Approvals, Clinical Trials, and Pipeline 2024 …
DelveInsight's, "Alpha1-Antitrypsin Deficiency Pipeline Insight 2024" report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in the Alpha1-Antitrypsin Deficiency pipeline landscape. It covers…
Constipation FDA Approvals, Clinical Trials, Emerging Drugs and Companies 2024 | …
DelveInsight's, "Constipation Pipeline Insight 2024" report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in the Constipation pipeline landscape. It covers the Constipation…
Myositis FDA Approvals, Clinical Trials, and Pipeline Insights 2024 | Janssen Re …
DelveInsight's, "Myositis Pipeline Insight 2024" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in the Myositis pipeline landscape. It covers the Myositis…
Behçet's Disease FDA Approvals, Pipeline Insights, and Companies 2024 | AbbVie, …
DelveInsight's, "Behçet's Disease Pipeline Insight 2024" report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Behçet's Disease pipeline landscape. It covers Behçet's…
Advanced Melanoma FDA Approvals, Drugs, Pipeline Outlook 2024 | OncoSec Medical, …
DelveInsight's, "Advanced Melanoma Pipeline Insight 2024" report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in Advanced Melanoma pipeline landscape. It covers the…
Advanced Kidney Cancer FDA Approvals, Drugs, Pipeline Outlook 2024 | Janux Thera …
DelveInsight's, "Advanced Kidney Cancer Pipeline Insight 2024" report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in Advanced Kidney Cancer pipeline landscape. It…
Acute Graft-Versus-Host Disease FDA Approvals, Drugs, Pipeline Outlook 2024 | Ma …
DelveInsight's, "Acute Graft-versus-Host Disease Pipeline Insight, 2024," report provides comprehensive insights about 21+ companies and 23+ pipeline drugs in Acute Graft-versus-Host Disease pipeline landscape. It…
Bile Duct Cancer (Cholangiocarcinoma) Drugs, FDA Approvals, Pipeline Outlook 202 …
DelveInsight's, "Bile Duct Cancer (Cholangiocarcinoma) Pipeline Insight 2024" report provides comprehensive insights about 50+ companies and 60+ pipeline drugs in Bile Duct Cancer (Cholangiocarcinoma) pipeline…
T-cell Malignancies Drugs, FDA Approvals, Pipeline Outlook 2024 | AB Science, Co …
DelveInsight's, "T-cell Malignancies Pipeline Insight 2024" report provides comprehensive insights about 80+ companies and 82+ pipeline drugs in T-cell Malignancies pipeline landscape. It covers the…
Refractory Epilepsy Market to Witness Growth by 2032 | Novartis AG, Abbott Labor …
DelveInsight's "Refractory Epilepsy Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Refractory Epilepsy, historical and forecasted epidemiology as well as the…
Septic Arthritis Market to Witness Growth by 2032 | Adrenomed AG, Vivacelle Bio, …
DelveInsight's "Septic Arthritis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Septic Arthritis, historical and forecasted epidemiology as well as the…
Blepharitis Market to Witness Growth by 2032 | Scope Ophthalmic Ltd., Novartis A …
DelveInsight's "Blepharitis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Blepharitis, historical and forecasted epidemiology, and the Blepharitis market trends in…
Mucopolysaccharidosis Market to Witness Growth by 2032 | BioMarin, Takeda Pharma …
DelveInsight's "Mucopolysaccharidosis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Mucopolysaccharidosis, historical and forecasted epidemiology, and the Mucopolysaccharidosis market trends in…
Bacterial Conjunctivitis Market to Witness Growth by 2032 | Allergan, Alembic Ph …
DelveInsight's "Bacterial Conjunctivitis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Bacterial Conjunctivitis, historical and forecasted epidemiology as well as the…
Epstein-Barr Virus Market Size is expected to grow by 2032, estimates DelveInsig …
DelveInsight's "Epstein-Barr Virus Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Epstein-Barr Virus, historical and forecasted epidemiology as…
Parkinson's Disease- Patient Pool Analysis, Market Size and Market Forecast APAC …
DelveInsight's "Parkinson's Disease- Patient Pool Analysis, Market Size and Market Forecast APAC, 2034" report comprises of detailed understanding of the Parkinson's Disease, historical and forecasted…
EGFR Inhibitors-Induced Skin Disorders Market Size is expected to grow by 2032, …
DelveInsight's "EGFR Inhibitors-Induced Skin Disorders Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the EGFR Inhibitors-Induced Skin Disorders, historical…
Invasive Pneumococcal Disease Market SIze is expected to grow by 2032, estimates …
(Albany, USA) DelveInsight's "Invasive Pneumococcal Disease Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Invasive Pneumococcal Disease, historical and forecasted epidemiology…
Surgical Site Infections Market Size is expected to grow by 2032, estimates Delv …
DelveInsight's "Surgical Site Infections Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Surgical Site Infections, historical and forecasted…
Atopic Dermatitis Competitive Landscape Report (Updated) | Eli Lilly and Company …
DelveInsight's, "Atopic Dermatitis Competitive Landscape" report provides comprehensive insights about 100+ Atopic Dermatitis companies and 110+ drugs in the Atopic Dermatitis Competitive landscape. It covers…
Asthma Competitive Landscape Report (Updated) | Areteia Therapeutics, Celltrion, …
DelveInsight's, "Asthma Competitive Landscape" report provides comprehensive insights about 110+ Asthma companies and 125+ drugs in Asthma Competitive landscape. It covers the Asthma therapeutics assessment…
Chronic Kidney Disease Competitive Landscape Report (Updated) | Boehringer Ingel …
DelveInsight's, "Chronic Kidney Disease Competitive Landscape" report provides comprehensive insights about 75+ Chronic Kidney Disease Companies and 95+ drugs in the Chronic Kidney Disease Competitive…
RNA Interference Therapy Competitive Landscape Report (Updated) | Silence Therap …
DelveInsight's, "RNA Interference Therapy Competitive Landscape" report provides comprehensive insights about 40+ RNA Interference Therapy companies and 90+ drugs in RNA Interference Therapy Competitive landscape.…
Glaucoma Competitive Landscape Report (Updated) | Santen Pharmaceuticals, Visiox …
DelveInsight's, "Glaucoma Competitive Landscape" report provides comprehensive insights about 45+ Glaucoma companies and 50+ drugs in Glaucoma Competitive landscape. It covers the Glaucoma therapeutics assessment…
